Efficacy and safety of prothrombin complex concentrate for vitamin K antagonist-associated intracranial hemorrhage: a systematic review and meta-analysis

被引:10
作者
Pan, Rui [1 ]
Cheng, Jinping [2 ]
Lai, Kelin [1 ]
Huang, Qing [3 ]
Wu, Hui [1 ]
Tang, Yamei [2 ]
机构
[1] Huizhou Hlth Sci Polytech, Dept Nursing, Huizhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurol, Guangzhou 510120, Guangdong, Peoples R China
[3] Huizhou Hlth Sci Polytech, Dept Basic Courses, Huizhou, Guangdong, Peoples R China
基金
国家重点研发计划;
关键词
Intracranial hemorrhage; Vitamin K antagonists; Prothrombin complex concentrate; Meta-analysis; FRESH-FROZEN PLASMA; INTERNATIONAL NORMALIZED RATIO; FACTOR-IX COMPLEX; INTRACEREBRAL HEMORRHAGE; ANTICOAGULATION REVERSAL; WARFARIN; GUIDELINES; MANAGEMENT; COAGULOPATHY; ENLARGEMENT;
D O I
10.1007/s10072-019-3726-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Prothrombin complex concentrate (PCC) is the treatment of choice in vitamin K antagonist-associated intracranial hemorrhage (VKA-ICH). However, the efficiency and safety associated with their use remain unclear. Aims This study aimed to assess the current evidence of the clinical outcomes in patients with VKA-ICH treated with or without PCC. Summary of review A meta-analysis was conducted. Two randomized controlled trials and 19 observational studies were included. PCC use demonstrated a significant increased likelihood of international normalized ratio (INR) normalization (OR=3.76; 95% CI 1.74-8.12), shortened time to INR correction (MD=-1.30; 95% CI -2.08 to -0.53) and reduction of hematoma expansion (HE) rate (OR=0.37; 95% CI 0.23-0.60). Although PCC use revealed a statistical reduction at 30-day mortality (OR=0.62; 95% CI 0.50-0.78), the result was inconsistent with mortality at discharge (OR=1.03; 95% CI 0.68-1.57) and 90-day follow-up (OR=0.50; 95% CI 0.24-1.07), both of which yielded no significant difference. When subgroup analyses were performed focus on PCC only treatment with FFP, no statistically significant difference was observed in 30-day mortality (OR=0.43; 95% CI 0.11-1.71) as well. Besides, significant difference was not found in neurologic improvement at discharge (OR=1.85; 95% CI 0.32-10.75), 30-day follow-up (OR=3.00; 95% CI 0.93-9.70), or 90-day follow-up (OR=1.55; 95% CI 0.84-2.86). No statistically significant difference was noted in the risk of thromboembolism following PCC administration (OR=0.61; 95% CI 0.23-1.63). Conclusions PCC use for VKA-ICH reversal was associated with a significant reduction in INR and HE rate, without an increased risk of thromboembolic events. However, this reduction was not associated with improvement in neurologic deficits or overall survival. Well-designed randomized trials with special considerations to the aspect are necessary.
引用
收藏
页码:813 / 827
页数:15
相关论文
共 50 条
[31]   Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis [J].
Khatib, Rasha ;
Ludwikowska, Maja ;
Witt, Daniel M. ;
Ansell, Jack ;
Clark, Nathan P. ;
Holbrook, Anne ;
Wiercioch, Wojtek ;
Schunemann, Holger ;
Nieuwlaat, Robby .
BLOOD ADVANCES, 2019, 3 (05) :789-796
[32]   Safety and efficacy of intravenous thrombolysis in acute ischemic stroke patients with a history of intracranial hemorrhage: A systematic review and meta-analysis [J].
Gajurel, Bikram Prasad ;
Nepal, Gaurav ;
Kharel, Sanjeev ;
Yadav, Jayant Kumar ;
Yadav, Sushil Kumar ;
Shing, Yow Ka ;
Goeschl, Stella ;
Thapaliya, Sahil .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2022, 215
[33]   Safety and efficacy of prothrombin complex concentrate (PCC) for anticoagulation reversal in patients undergoing urgent neurosurgical procedures: a systematic review and metaanalysis [J].
Faulkner, Harrison ;
Chakankar, Shubham ;
Mammi, Marco ;
Lo, Jack Yu Tung ;
Doucette, Joanne ;
Al-otaibi, Nawaf ;
Abboud, Judi ;
Le, Andrew ;
Mekary, Rania A. ;
Bunevicius, Adomas .
NEUROSURGICAL REVIEW, 2021, 44 (04) :1921-1931
[34]   Three-Factor Versus Four-Factor Prothrombin Complex Concentrate for the Emergent Management of Warfarin-Associated Intracranial Hemorrhage [J].
Fischer, Daniel ;
Sorensen, Jeffrey ;
Fontaine, Gabriel V. .
NEUROCRITICAL CARE, 2018, 28 (01) :43-50
[35]   Combination Therapy Using Prothrombin Complex Concentrate and Vitamin K in Anticoagulated Patients with Traumatic Intracranial Hemorrhage Prevents Progressive Hemorrhagic Injury: A Historically Controlled Study [J].
Koyama, Hiroshi ;
Yagi, Kenji ;
Hara, Keijiro ;
Matsubara, Shunji ;
Tao, Yoshifumi ;
Uno, Masaaki .
NEUROLOGIA MEDICO-CHIRURGICA, 2021, 61 (01) :47-54
[36]   Comparison of 3-factor versus 4-factor prothrombin complex concentrate for emergent warfarin reversal: a systematic review and meta-analysis [J].
Margraf, David J. ;
Brown, Sarah J. ;
Blue, Heather L. ;
Bezdicek, Tamara L. ;
Wolfson, Julian ;
Chapman, Scott A. .
BMC EMERGENCY MEDICINE, 2022, 22 (01)
[37]   The impact of the approval of prothrombin complex concentrates for vitamin K antagonist-related intracerebral hemorrhage: A retrospective study [J].
Watanabe, Sadayoshi ;
Matsumoto, Shoji ;
Nakahara, Ichiro ;
Morioka, Jun ;
Hasebe, Akiko ;
Tanabe, Jun ;
Suyama, Kenichiro ;
Ishihara, Takuma ;
Ohta, Tsuyoshi ;
Hatano, Taketo ;
Nagata, Izumi ;
Hirose, Yuichi .
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2022, 31 (12)
[38]   Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patients [J].
Johansen, Mathias ;
Wikkelso, Anne ;
Lunde, Jens ;
Wetterslev, Jorn ;
Afshari, Arash .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (07)
[39]   Andexanet Alfa or Prothrombin Complex Concentrate for Factor Xa Inhibitor Reversal in Acute Major Bleeding: A Systematic Review and Meta-Analysis [J].
Nederpelt, Charlie J. ;
Naar, Leon ;
Krijnen, Pieta ;
le Cessie, Saskia ;
Kaafarani, Haytham M. A. ;
Huisman, Menno V. ;
Velmahos, George C. ;
Schipper, Inger B. .
CRITICAL CARE MEDICINE, 2021, 49 (10) :E1025-E1036
[40]   RISK OF VENOUS THROMBOEMBOLISM AFTER RECEIVING PROTHROMBIN COMPLEX CONCENTRATE FOR WARFARIN-ASSOCIATED INTRACRANIAL HEMORRHAGE [J].
Felton, Diana ;
Foley, Elizabeth M. ;
Traub, Stephen J. ;
Vodonos, Alina ;
Ganetsky, Michael .
JOURNAL OF EMERGENCY MEDICINE, 2016, 50 (01) :1-6